# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-24-022430
Filing Date
2024-04-26
Accepted
2024-04-26 16:05:42
Documents
4
Period of Report
2024-06-13

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | ny20025493x2_def14a.htm | DEF 14A | 1944933
2 |  | logo_adc2.jpg | GRAPHIC | 47456
3 |  | ny20025493x2_pc01.jpg | GRAPHIC | 510643
4 |  | ny20025493x2_pc02.jpg | GRAPHIC | 1632118
| Complete submission text file | 0001140361-24-022430.txt |  | 4961639

Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Filer) CIK: 0001771910 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39071 | Film No.: 24883568
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)